Science & Enterprise subscription

Please share Science & Enterprise

RSS
Follow by Email
Facebook
Facebook
Google+
Twitter
Visit Us
LinkedIn
INSTAGRAM

Stem Cell Transplants Found Safe for Spinal Cord Injuries

Spine model

Results from a clinical trial testing transplants of neural stem cells for spinal cord injuries show the therapies are safe for patients, with signs of improvement in most participants 1 to 2 years after treatment. . . . → Read More: Stem Cell Transplants Found Safe for Spinal Cord Injuries

FDA Delays Crispr Trial for Inherited Blood Diseases

Crispr-Cas9 illustration

The U.S. Food and Drug Administration put a hold on beginning a clinical trial of the emerging genome editing technique known as Crispr to treat inherited blood disorders. . . . → Read More: FDA Delays Crispr Trial for Inherited Blood Diseases

Clinical Trials Okayed for Sickle Cell Gene Editing

Sickle cell illustration

Two companies developing therapies for inherited blood disorders say the Food and Drug Administration approved their application to begin clinical trials of treatments for sickle cell disease with gene editing. . . . → Read More: Clinical Trials Okayed for Sickle Cell Gene Editing

Computer-Designed Heart Valves Operate Over Long Term

Engineered heart valve

A European research team designed customized heart valves with computer models, which when tested in sheep continued to perform in most cases for a year following implantation. . . . → Read More: Computer-Designed Heart Valves Operate Over Long Term

Crowdfunding Found Supporting Dubious Stem Cell Clinics

Crowdfunding graphic

More people now use crowdfunding campaigns to raise money to cover families’ medical costs, but the technique is also used to support treatments from stem cell clinics that exaggerate their outcomes and minimize their risks. . . . → Read More: Crowdfunding Found Supporting Dubious Stem Cell Clinics

Stem Cell Eye Implants Safe, Stop Visual Function Loss

Early results from a clinical trial show implants of replacement retina cells grown from stem cells are safe for people with a form of age-related macular degeneration, and at least stop the loss of visual function. . . . → Read More: Stem Cell Eye Implants Safe, Stop Visual Function Loss

Lilly, Cell Implants Start-Up Partner on Diabetes

Eli Lilly and Company is licensing a technology for implanting pancreatic beta cells in people with type 1 diabetes, from Sigilon Therapeutics Inc., an enterprise making implants of live cells to treat chronic diseases. . . . → Read More: Lilly, Cell Implants Start-Up Partner on Diabetes

Crispr Techniques Devised for Editing RNA

Geneticists and bioengineers developed a technology for applying genomic editing techniques known as Crispr to ribonucleic acid, or RNA, transcribed from the genetic code in a person’s DNA. . . . → Read More: Crispr Techniques Devised for Editing RNA

Company Formed to Develop Cancer Cell Therapies

The MD Anderson Cancer Center in Houston is starting Optera Therapeutics Corp., a new company to commercialize its research on treating cancer with a patients’ own immune system cells. . . . → Read More: Company Formed to Develop Cancer Cell Therapies

Techniques Devised to Boost Gene Therapy Success

An engineering team at Washington University in St. Louis is developing mechanical and electronic processes to improve the success of inserting large, complex therapeutic molecules like DNA into cells. . . . → Read More: Techniques Devised to Boost Gene Therapy Success